[Neuroblastoma: epidemiology and spontaneous remission. Significance for evaluation of screening studies]

[Article in Danish]

Affiliations

Review

[Article in Danish]

N L Carlsen. Ugeskr Laeger. 1992.

. 1992 Dec 21;154(52):3742-6.

No abstract available

Comment in

[Neuroblastoma: epidemiology and spontaneous remission. Significance for evaluation of screening studies].
Edeling CJ. Edeling CJ. Ugeskr Laeger. 1993 Mar 22;155(12):900. Ugeskr Laeger. 1993. PMID: 8480395 Danish. No abstract available.

Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.
Carlsen NL. Carlsen NL. Am J Pediatr Hematol Oncol. 1992 May;14(2):103-10. Am J Pediatr Hematol Oncol. 1992. PMID: 1530115 Review.
[Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
Sawada T, Nagahara N, Ohi R, Yamamoto K, Okabe I, Hanawa Y, Hashizume K, Matsui I, Ohkawa H, Tunoda A, et al. Sawada T, et al. Gan To Kagaku Ryoho. 1990 Dec;17(12):2319-26. Gan To Kagaku Ryoho. 1990. PMID: 2260868 Clinical Trial. Japanese.
[Therapy and prognosis of neuroblastoma. Report of 54 cases observed in Switzerland].
Taminelli F, Käser H, Wagner HP. Taminelli F, et al. Helv Paediatr Acta. 1970 Dec;25(6):554-65. Helv Paediatr Acta. 1970. PMID: 5515939 German. No abstract available.
Neuroblastoma sympathicum.
Koutecký J. Koutecký J. Acta Univ Carol Med Monogr. 1984;106:1-133. Acta Univ Carol Med Monogr. 1984. PMID: 6391118 Review. No abstract available.
Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
Yoneda A, Oue T, Imura K, Inoue M, Yagi K, Kawa K, Nishikawa M, Morimoto S, Nakayama M. Yoneda A, et al. Med Pediatr Oncol. 2001 Jan;36(1):160-2. doi: 10.1002/1096-911X(20010101)36:1<160::AID-MPO1039>3.0.CO;2-G. Med Pediatr Oncol. 2001. PMID: 11464874